Highly elevated systemic inflammation is a strong independent predictor of early mortality in advanced non-small cell lung cancer
Background: Ample evidence support inflammation as a marker of outcome in non-small cell lung cancer (NSCLC). Here we explore the outcome for a subgroup of patients with advanced disease and substantially elevated systemic inflammatory activity. Methods: The source cohort included consecutive patien...
Na minha lista:
| Principais autores: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier
2022-01-01
|
| coleção: | Cancer Treatment and Research Communications |
| Assuntos: | |
| Acesso em linha: | http://www.sciencedirect.com/science/article/pii/S2468294222000466 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|
